Medlive Technology Co (FRA:1JZ) ROCE %: 7.88% (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:1JZ Medlive Technology Co Ltd FRA:1JZ
90 GF Score
Price €0.84
GF Value €1.61
! 5 Warning Signs
View Full Analysis

What is Medlive Technology Co ROCE %?

Medlive Technology Co FRA:1JZ +2.93% 90 ROCE % is 7.88% as of Dec. 2025. GuruFocus rates FRA:1JZ with a GF Score™ of 90/100 and a GF Value™ of €1.61. The stock has 5 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Medlive Technology Co's annualized ROCE % for the quarter that ended in Dec. 2025 was 7.88%.

Medlive Technology Co  (FRA:1JZ) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Medlive Technology Co ROCE % Related Terms

Medlive Technology Co ROCE % Historical Data

* Premium members only.

The historical data trend for Medlive Technology Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medlive Technology Co ROCE % Chart

Medlive Technology Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial 3.40 3.16 5.38 7.18 7.04

Medlive Technology Co Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.42 6.66 7.64 6.51 7.88
FRA:1JZ
90GF Score
Medlive Technology Co Ltd FRA:1JZ
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medlive Technology Co ROCE % Calculation

Medlive Technology Co's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=43.752/( ( (670.034 - 27.166) + (625.299 - 25.354) )/ 2 )
=43.752/( (642.868+599.945)/ 2 )
=43.752/621.4065
=7.04 %

Medlive Technology Co's ROCE % of for the quarter that ended in Dec. 2025 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=47.052/( ( (616.909 - 22.341) + (625.299 - 25.354) )/ 2 )
=47.052/( ( 594.568 + 599.945 )/ 2 )
=47.052/597.2565
=7.88 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 7.88% mean?
Medlive Technology Co (FRA:1JZ) has a ROCE % of 7.88% as of Dec. 2025.
Is Medlive Technology Co's ROCE % too high?
Medlive Technology Co's current ROCE % is 7.88%. The Healthcare Providers & Services industry median ROCE % is 6.52. Medlive Technology Co's value of 7.88% is 21% above this industry median. Overall, Medlive Technology Co has a GF Score™ of 90/100, reflecting its overall financial health beyond just this single metric.
How does Medlive Technology Co's ROCE % compare to VEEV and BTSG?
Medlive Technology Co's ROCE % of 7.88% can be compared against companies in the Healthcare Providers & Services industry. The industry median ROCE % is 6.52. Medlive Technology Co's value of 7.88% is 21% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Healthcare Providers & Services company?
The median ROCE % among Healthcare Providers & Services companies is 6.52, based on 640 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medlive Technology Co's current ROCE % of 7.88% is 21% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median ROCE % is 6.52 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medlive Technology Co's current ROCE % is 7.88%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medlive Technology Co stock overvalued right now?
Medlive Technology Co (FRA:1JZ) has a current ROCE % of 7.88%. The stock's GF Value™ is €1.61, compared to a current price of €0.84 — trading 47.6% below its estimated fair value. The current ROCE % is 7.88% and 21% above the Healthcare Providers & Services industry median of 6.52. Medlive Technology Co's overall GF Score™ is 90/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Medlive Technology Co (FRA:1JZ), the current ROCE % is 7.88% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medlive Technology Co (FRA:1JZ) Overvalued in 2026?

Based on GuruFocus' analysis, Medlive Technology Co stock appears to be undervalued. The current stock price of €0.84 is trading 47.6% below its estimated GF Value™ of €1.61.

Key valuation signals for FRA:1JZ:

  • ROCE %: 7.88%
  • GF Value™: €1.61 vs. price of €0.84 (47.6% below fair value)
  • GF Score™: 90/100 with 5 warning signs
  • Industry Position: 21% above the Healthcare Providers & Services median

No single metric tells the full story. See the FRA:1JZ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Medlive Technology Co Business Description

Other Exchanges 02192:Hong Kong
Address Huangqu East Road No. 5, Courtyard Building 4, Yimaitong Mansion, Chaoyang District, Beijing, CHN
Medlive Technology Co Ltd is a digital healthcare marketing company that produces customized content for pharmaceutical and medical device firms. The company developed into a professional provider of medical information services and precision digital marketing services. Its platform also provides medical content consisting of third-party research, informal discussions, and medical news articles. The company also operates a minor internet hospital and a SaaS solution that helps with medical conferences and clinical research.
90GF Score

Get the complete analysis for FRA:1JZ

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.84
Price
€1.61
GF Value